Myfortic – Mycophenolate Sodium Tablet
MYCOPHENOLATE SODIUM (MYFORTIC) TABLET – TREATMENT FOR PREVENTION OF ORGAN REJECTION IN TRANSPLANT PATIENTS
Mycophenolate Sodium or Myfortic Tablet is a member of the immunosuppressant class of drugs. It is combined with other medications to stop your body from rejecting a transplanted organ (such as a kidney, heart, or liver). It functions by making your immune system less effective so that it won’t fight the transplanted organ.
Depending on the type of transplant you have, you should take a different dose of Myfortic Tablet. Observe your doctor’s advice in this regard.
USES OF MYCOPHENOLATE SODIUM (MYFORTIC) TABLET
- Prevention of organ rejection in transplant patients
WORKS OF MYCOPHENOLATE SODIUM (MYFORTIC) TABLET
An immunosuppressant is Myfortic Tablet. It lessens the body’s immune system’s activity and prevents the donated organ from being rejected.
SIDE EFFECTS OF MYCOPHENOLATE SODIUM (MYFORTIC) TABLET
- Abdominal pain
- High blood pressure
- Decreased white blood cell count (neutrophils)
WARNING & PRECAUTIONS
Your ability to drive is typically unaffected by Myfortic Tablet.
Patients with kidney conditions can probably use Myfortic Tablet without risk. There isn’t enough information to say whether these people require a dose adjustment for Myfortic Tablet. Please speak with your physician.
Patients with liver disease can probably use Myfortic Tablet without risk. There isn’t enough information to say whether these people require a dose adjustment for Myfortic Tablet. Please speak with your physician.
Fedelty Health Care is a Mycophenolate Sodium third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.